Liposomal formulation of irinotecan
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 17, 2006
Grant Date -
Jan 27, 2005
app pub date -
Nov 19, 2003
filing date -
May 29, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is for novel compositions and methods for treating cancer, particularly, for treating cancer in mammals and more particularly in humans. The therapeutic compositions of the present invention include liposome entrapped irinotecan in which the liposome can contain any of a variety of neutral or charged liposome-forming compounds and cardiolipin. The liposomes of the present invention can be either multilamellar vesicles and unilamellar vesicles, as desired.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully